Literature DB >> 3520876

Anaphylactic and anaphylactoid reactions. A review.

J H Levy, M F Roizen, J M Morris.   

Abstract

Anaphylaxis is a life-threatening, immunologically mediated reaction. "Anaphylactoid" reactions produce the same clinical syndrome but are not immunologically mediated. Vasoactive mediators of these reactions include histamine, eosinophilic chemotactic factors of anaphylaxis, slow reacting substance of anaphylaxis (a mixture of three leukotrienes, one a potent coronary vasoconstrictor), kinins, and prostaglandins. Symptoms usually occur within 15 minutes of parenteral injection of the causative agent, but can be delayed as long as 2.5 hours. Because vasodilation occurs at the capillary and postcapillary venule, resulting in loss of fluid and colloid (and hence reduction in effective plasma volume), and then shock, volume replacement is a mainstay of therapy. This article reviews the pathophysiology, incidence, and drug causes of anaphylactic/anaphylactoid reactions and proposes therapy to minimize the consequences of reactions seen by physicians treating spinal conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3520876     DOI: 10.1097/00007632-198604000-00017

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

Review 1.  Peri-operative anaphylaxis.

Authors:  Linda Nel; Efrem Eren
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  5-HMF induces anaphylactoid reactions in vivo and in vitro.

Authors:  Encan Li; Ni Lin; Ruirui Hao; Xiaoyu Fan; Lin Lin; Guang Hu; Sheng Lin; Jiuming He; Qingfen Zhu; Hongtao Jin
Journal:  Toxicol Rep       Date:  2020-10-16

3.  Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers.

Authors:  R E Polk; D Israel; J Wang; J Venitz; J Miller; J Stotka
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

4.  Preparation and Evaluation of Lipid Emulsion Containing 13 Vitamins for Injection Without Anaphylactoid Reactions.

Authors:  Min-Quan Hui; Yan-Ni Mi; Yu-Fan Ma; Tao Chen; Yong-Xiao Cao
Journal:  Int J Nanomedicine       Date:  2021-05-12

5.  Effects of 3 Different Commercial Vaccines Formulations against BVDV and BHV-1 on the Inflammatory Response of Holstein Heifers.

Authors:  Camila Costa Baccili; Camila Cecilia Martin; Nathália Decaris; Karina Medici Madureira; Christopher Chase; Viviani Gomes
Journal:  Vet Sci       Date:  2019-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.